USANA HEALTH SCIENCES, INC. financials

  1. Home
  2. Financials
  3. USNA
USNA CIK 0000896264

Source: EDGAR filings · Built 2026-06-02T04:17:44Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2023FY 2023FY 2022FY 2022FY 2020
Free Cash Flow 8.53M 50.92M 56.15M 93.50M 108.46M 145.31M
EBITDA 69.99M 80.86M 105.77M 121.01M 183.23M 190.24M
Working Capital 159.84M 139.56M 298.90M 240.55M 204.33M 257.21M
Net Debt -140.42M -165.56M -318.00M -273.85M -222.54M -303.30M
Gross Margin 78.29% 81.13% 80.82% 80.58% 81.63% 81.57%
Operating Margin 4.05% 7.76% 10.11% 10.78% 14.34% 15.55%
Net Margin 1.16% 4.92% 6.93% 6.94% 9.82% 10.99%
Return on Equity (ROE) 2.02% 7.90% 12.83% 15.96% 29.49% 28.23%
Return on Assets (ROA) 1.45% 5.62% 10.08% 11.63% 20.17% 19.45%
Current Ratio 2.24× 2.00× 3.52× 2.67× 2.27× 2.53×
Debt-to-Equity 0.03× 0.03× 0.03× 0.03× 0.04× 0.02×
Effective Tax Rate 72.36% 44.91% 37.74% 36.15% 31.73% 29.94%
Cash Conversion Ratio 2.08× 1.45× 1.11× 1.50× 1.04× 1.29×
Accruals Ratio -0.02× -0.03× -0.01× -0.06× -0.01× -0.06×
SBC % of Revenue 1.49% 1.70% 1.58% 1.33% 1.21% 1.27%
CapEx Coverage 1.62× 6.05× 4.87× 9.99× 9.50× 10.63×
Free Cash Flow Per Share $0.46 $2.66 $2.90 $4.84 $5.33 $6.84

Valuation Metrics

Concept FY 2025FY 2023FY 2023FY 2022FY 2022FY 2020
P/E Trailing (Diluted) 33.52× 16.30× 16.24× 14.82× 17.66× 13.16×
P/FCF 42.35× 13.43× 18.47× 10.99× 18.98× 11.28×
FCF Yield 2.36% 7.45% 5.41% 9.10% 5.27% 8.87%
EV / EBITDA 3.07× 6.37× 6.69× 6.18× 9.50× 6.93×
P/S 0.38× 0.80× 1.11× 1.02× 1.65× 1.43×
P/B 0.67× 1.28× 2.06× 2.35× 4.97× 3.67×

Income Statement

Concept FY 2025FY 2023FY 2023FY 2022FY 2022FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax 925.26M 854.50M 921.01M 998.60M 1.19B 1.13B
Cost of Goods and Services Sold 200.85M 161.21M 176.69M 193.89M 217.90M 209.11M
Gross Profit 724.40M 693.29M 744.32M 804.71M 968.57M 925.53M
Research and Development Expense 10.69M 11.57M 11.45M 11.56M 11.11M 10.63M
Selling, General and Administrative Expense 337.37M 263.27M 256.99M 262.30M 279.11M 261.19M
Operating Expenses 686.97M 626.97M 651.25M 697.10M 798.37M 749.04M
Operating Income (Loss) 37.43M 66.32M 93.07M 107.61M 170.19M 176.49M
Income Tax Expense (Benefit) 30.05M 34.29M 38.66M 39.27M 54.14M 53.28M
Net Income (Loss) Attributable to Parent 10.76M 42.03M 63.79M 69.35M 116.50M 124.66M
Earnings Per Share, Basic $0.58 $2.20 $3.31 $3.60 $5.78 $5.89
Weighted Average Number of Shares Outstanding, Basic 18.54M 19.10M 19.25M 19.25M 20.15M 21.16M
Earnings Per Share, Diluted $0.58 $2.19 $3.30 $3.59 $5.73 $5.86
Weighted Average Number of Shares Outstanding, Diluted 18.57M 19.16M 19.34M 19.31M 20.34M 21.26M

Balance Sheet

Concept FY 2025FY 2023FY 2023FY 2022FY 2022FY 2020
Cash and Cash Equivalents, at Carrying Value 158.38M 181.77M 330.42M 288.42M 239.83M 311.92M
Assets, Current 288.40M 279.19M 417.75M 384.38M 365.12M 425.29M
Assets 742.91M 748.19M 632.76M 596.55M 577.74M 640.89M
Liabilities, Current 128.56M 139.63M 118.84M 143.83M 160.79M 168.07M
Liabilities 156.64M 161.86M 135.56M — — —
Stockholders' Equity Attributable to Parent 533.10M 532.11M 497.20M 434.47M 395.12M 441.65M
Common Stock, Shares, Outstanding 18.28M 19.06M 19.13M 19.21M 19.39M 21.04M

Cash Flow Statement

Concept FY 2025FY 2023FY 2023FY 2022FY 2022FY 2020
Net Cash Provided by (Used in) Operating Activities 22.35M 60.99M 70.64M 103.90M 121.23M 160.40M
Payments to Acquire Property, Plant, and Equipment 13.82M 10.07M 14.49M 10.40M 12.76M 15.09M
Net Cash Provided by (Used in) Investing Activities -10.13M -213.09M -11.97M -12.37M -14.19M -33.96M
Payments for Repurchase of Common Stock 27.51M 9.44M 11.60M 25.38M 177.84M 57.03M
Net Cash Provided by (Used in) Financing Activities -40.60M 9.55M -14.24M -30.09M -181.41M -59.44M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (USNA CIK 0000896264), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

RBRK

RUBRIK, INC.

ASLE

AerSale Corporation

HBNC

HORIZON BANCORP, INC.